clinical pharmacology and therapeutics | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

clinical pharmacology and therapeutics

Indexings
ncbi
Short Name clin pharmacol ther
Abbreviated Name clin pharmacol ther
ISSN 1532-6535
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (11 total)

2020
Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.
Conrado, Daniela J;Duvvuri, Sridhar;Geerts, Hugo;Burton, Jackson;Biesdorf, Carla;Ahamadi, Malidi;Macha, Sreeraj;Hather, Gregory;Morales, Juan Francisco;Podichetty, Jagdeep;Nicholas, Timothy;Stephenson, Diane;Trame, Mirjam;Romero, Klaus;Corrigan, Brian;, ;
321 views DOI Abstract
2020
Development of a System for Post-marketing Population Pharmacokinetic and Pharmacodynamic Studies using Real-World Data from Electronic Health Records.
Choi, Leena;Beck, Cole;McNeer, Elizabeth;Weeks, Hannah L;Williams, Michael L;James, Nathan T;Niu, Xinnan;Abou-Khalil, Bassel W;Birdwell, Kelly A;Roden, Dan M;Stein, C Michael;Bejan, Cosmin A;Denny, Joshua C;Van Driest, Sara L;
319 views DOI Abstract
2020
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
Damle, Bharat;Vourvahis, Manoli;Wang, Erjian;Leaney, Joanne;Corrigan, Brian;
317 views DOI Abstract
2002
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund, Werner;Ludwig, Karen;Giessmann, Thomas;Dazert, Peter;Schroeder, Eike;Sperker, Bernhard;Warzok, Rolf;Kroemer, Heyo K;Cascorbi, Ingolf;
Vol. 72 , No. 5 , pp. 572-83
308 views Abstract
2019
Model-informed dose selection for Xentuzumab, a dual insulin-like growth factor-I/II -neutralizing antibody.
Parra-Guillen, Zinnia P;Schmid, Ulrike;Janda, Alvaro;Freiwald, Matthias;Troconiz, IΓ±aki F;
291 views DOI Abstract
2020
MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.
Krishnaswami, Sriram;Austin, Daren;Della Pasqua, Oscar;Gastonguay, Marc R;Gobburu, Jogarao;van der Graaf, Piet H;Ouellet, Daniele;Tannenbaum, Stacey;Visser, Sandra A G;
274 views DOI Abstract
2019
Can Insights From Placebo and Nocebo Mechanism Studies Help Improve Randomized Controlled Trials?
Vase, Lene;
248 views DOI
2002
Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.
Siegmund, Werner;Altmannsberger, Stephan;Paneitz, Andrea;Hecker, Ute;Zschiesche, Michael;Franke, Gerd;Meng, Wieland;Warzok, Rolf;Schroeder, Eike;Sperker, Bernhard;Terhaag, Bernd;Cascorbi, Ingolf;Kroemer, Heyo K;
Vol. 72 , No. 3 , pp. 256-64
234 views Abstract
2020
Target adverse event profiles for predictive safety in the post-market setting.
Schotland, Peter;Racz, Rebecca;Jackson, David B;Soldatos, Theodoros G;Levin, Robert;Strauss, David;Burkhart, Keith;
209 views DOI Abstract
2020
Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2
Thakur A;Tan SPF;Chan JCY;;
, pp. -
198 views Abstract
View All 11 Articles
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament